Follow the Integrated Biopharma INC share price and the full insider trade history of the company, a publicly traded company based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Operating in the Health Care sector, Integrated Biopharma INC has recorded 26 public disclosures. Market capitalisation: €5m. The latest transaction was reported on 17 April 2026 (Don). Among the most active insiders: Milmoe William H.. Every trade is free.
26
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
33Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 5,762 of 29,064 companies
66.9
score / 100
Value
97
Quality
37
FCF yld37%
Earn yld16%
EV/EBITDA1.8x
ROE-8.4%
Gross mgn10%
Net mgn1.5%
Debt/EBITDA0.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.